Publication | Closed Access
Hesperetin and Naringenin sensitize HER2 positive cancer cells to death by serving as HER2 Tyrosine Kinase inhibitors
89
Citations
39
References
2016
Year
OncologyOncogenic AgentMedicineCell DeathCancer BiologyPharmacotherapyAnti-cancer AgentCancer TreatmentPharmacologyCell BiologyCancer ResearchTumor Biology
| Year | Citations | |
|---|---|---|
Page 1
Page 1